Study for the Multi-Center Placebo-Controlled Double-Blind Clinical Trial for the Evaluation of the Effect of Cilostazol on Pulsatility Index of Transcranial Doppler in the Acute Lacunar Infarction Patients.

Trial Profile

Study for the Multi-Center Placebo-Controlled Double-Blind Clinical Trial for the Evaluation of the Effect of Cilostazol on Pulsatility Index of Transcranial Doppler in the Acute Lacunar Infarction Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Cilostazol (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Pharmacodynamics
  • Acronyms ECLIPse
  • Most Recent Events

    • 01 Feb 2013 Primary endpoint 'Pulsatility-index' has been met.
    • 02 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Oct 2009 Results have been presented at EFNS 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top